First-of-its-kind Noom Psychosocial GLP-1 Report finds more than 90% of GLP-1 users say medication helped them adopt healthier habits, with reported benefits extending beyond weight to quality of life, joy, and metabolic health Princeton, NJ, May 5, 2026 Noom, the leading behavior change company, today announced that Charles Duhigg Pulitzer Prizewinning journalist and author of The Power of Habit, one of the best-selling and most influential books on human behavior of the last decade has joined the company as an advisor focused on maximizing the impact of GLP-1s as habit catalysts
Diabetes, metabolic syndrome and obesity: targets and therapy, 10, 403412.
By 12 months, they had lost an average of 17.4% of their body weight
This requires that your physician document the necessity of the injections for treating a specific condition that aligns with Medicares guidelines